Mentice AB
STO:MNTC
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
20.7
55.2
|
| Price Target |
|
We'll email you a reminder when the closing price reaches SEK.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Mentice AB
Cost of Revenue
Mentice AB
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
M
|
Mentice AB
STO:MNTC
|
Cost of Revenue
-kr37.2m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
|
RaySearch Laboratories AB (publ)
STO:RAY B
|
Cost of Revenue
-kr106.6m
|
CAGR 3-Years
-35%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
N/A
|
|
|
ContextVision AB
OSE:CONTX
|
Cost of Revenue
-kr4.1m
|
CAGR 3-Years
-28%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-8%
|
|
|
O
|
Ortivus AB
STO:ORTI B
|
Cost of Revenue
-kr53.2m
|
CAGR 3-Years
8%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
N/A
|
|
|
Sectra AB
STO:SECT B
|
Cost of Revenue
-kr910.1m
|
CAGR 3-Years
-38%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
N/A
|
|
|
K
|
Kontigo Care AB
STO:KONT
|
Cost of Revenue
-kr10m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-134%
|
CAGR 10-Years
N/A
|
|
Mentice AB
Glance View
Mentice AB provides software and hardware simulation solutions for endovascular therapies. The company is headquartered in Goeteborg, Vastra Gotalands. The company went IPO on 2019-06-18. The company provides software and hardware simulation solutions and related services for endovascular therapies. The Company’s solutions help healthcare professionals acquire, retain, and enhance their procedural skills. The Company’s solutions are scientifically validated and have been specifically developed for healthcare providers and the medical device industry. The firm also covers neurovascular, cardiovascular and peripheral interventions, among others. The company is active globally.
See Also
What is Mentice AB's Cost of Revenue?
Cost of Revenue
-37.2m
SEK
Based on the financial report for Dec 31, 2023, Mentice AB's Cost of Revenue amounts to -37.2m SEK.
What is Mentice AB's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-5%
Over the last year, the Cost of Revenue growth was -28%. The average annual Cost of Revenue growth rates for Mentice AB have been -4% over the past three years , -5% over the past five years .
You don't have any saved screeners yet
